Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group.
Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group.
复制标题
DOI：
10.1016/s0149-2918(97)80092-6
复制
发表时间：
1997-07
影响因子：
3.2
通讯作者：
James E. Fish;James P. Kemp;R. Lockey;Mitchell Glass;Laura A Hanby;C. Bonuccelli
中科院分区：
文献类型：
--
作者：
James E. Fish;James P. Kemp;R. Lockey;Mitchell Glass;Laura A Hanby;C. Bonuccelli
